To investigate if topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic
lecitine organogel (AKL in PLO gel) can improve management of neuropathic pain from radiation
skin reactions adjunctively or better than standard treatment.
Phase:
Phase 3
Details
Lead Sponsor:
British Columbia Cancer Agency
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Ketamine Lidocaine